A randomized open-label observational study to compare the efficacy and tolerability between topiramate and valproate in juvenile myoclonic epilepsy

Journal of Clinical Neuroscience

Volumn 20, Issue 8, 2013, Pages 1079-1082

  Park, Kang Min ^a   Kim, Sang Ho ^b   Nho, Soon Ki ^c   Shin, Kyong Jin ^a   Park, Jinse ^a   Ha, Sam Yeol ^a   Kim, Sung Eun ^a  

^a Inje University College of Medicine   (South Korea)

^b Dong A University   (South Korea)

^c Department of Neurology   (South Korea)

Author keywords

Juvenile myoclonic epilepsy; Open label study; Randomization; Topiramate; Valproate

Indexed keywords

TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; FOLLOW UP; HAIR LOSS; HALLUCINATION; HUMAN; MALE; MYOCLONUS EPILEPSY; NAUSEA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARESTHESIA; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TREMOR; WEIGHT GAIN;

JUVENILE MYOCLONIC EPILEPSY; OPEN-LABEL STUDY; RANDOMIZATION; TOPIRAMATE; VALPROATE;

ADOLESCENT; ADULT; ELECTROENCEPHALOGRAPHY; FEMALE; FRUCTOSE; HUMANS; MALE; MYOCLONIC EPILEPSY, JUVENILE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VALPROIC ACID; YOUNG ADULT;

EID: 84879917166     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2012.10.020     Document Type: Article

References (31)

1. J. Anderson, and K. Hamandi Understanding juvenile myoclonic epilepsy: contributions from neuroimaging Epilepsy Res 94 2011 127 137
2. S. Auvin Treatment of juvenile myoclonic epilepsy CNS Neurosci Ther 14 2008 227 233
3. R.A. Grunewald, and C.P. Panayiotopoulos Juvenile myoclonic epilepsy. A review Arch Neurol 50 1993 594 598
4. R. Renganathan, and N. Delanty Juvenile myoclonic epilepsy: under-appreciated and under-diagnosed Postgrad Med J 79 2003 78 80
5. A.G. Marson, A.M. Al-Kharusi, and M. Alwaidh The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial Lancet 369 2007 1016 1026
6. J.J. Craig, and S.J. Hunt Treating women with juvenile myoclonic epilepsy Pract Neurol 9 2009 268 277
7. G. Montouris, and B. Abou-Khalil The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? Epilepsia 50 2009 16 20
8. A. Nicolson, and A.G. Marson When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy Pract Neurol 10 2010 208 218
9. V. Biton, G.D. Montouris, and F. Ritter A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group Neurology 52 1999 1330 1337
10. G.L. Morris, A.E. Hammer, and R.P. Kustra Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study Epilepsy Behav 5 2004 509 512
11. V. Biton, B.F. Bourgeois, and YTC/TCE Study Investigators Topiramate in patients with juvenile myoclonic epilepsy Arch Neurol 62 2005 1705 1708
12. S. Sousa Pda, G.M. Araujo Filho, and E. Garzon Topiramate for the treatment of juvenile myoclonic epilepsy Arq Neuropsiquiatr 63 2005 733 737
13. T. Glauser, E. Ben-Menachem, and B. Bourgeois ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes Epilepsia 47 2006 1094 1120
14. A. Labate, E. Colosimo, and A. Gambardella Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study Seizure 15 2006 214 218
15. L.M. Specchio, A. Gambardella, and A.T. Giallonardo Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy Epilepsy Res 71 2006 32 39
16. E. Trevathan, S.P. Kerls, and A.E. Hammer Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures Pediatrics 118 2006 e371 e378
17. P.M. Levisohn, and K.D. Holland Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison Epilepsy Behav 10 2007 547 552
18. S. Noachtar, E. Andermann, and P. Meyvisch Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures Neurology 70 2008 607 616
19. A. Verrotti, C. Cerminara, and G. Coppola Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents Dev Med Child Neurol 50 2008 29 32
20. W.E. Rosenfeld, S. Benbadis, and P. Edrich Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence. analysis of two randomized, double-blind, placebo-controlled studies Epilepsy Res 85 2009 72 80
21. M.D. Privitera, M.J. Brodie, and R.H. Mattson Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy Acta Neurol Scand 107 2003 165 175
22. S. Arroyo, W.E. Dodson, and M.D. Privitera Randomized dose-controlled study of topiramate as first-line therapy in epilepsy Acta Neurol Scand 112 2005 214 222
23. A.T. Berg, S.F. Berkovic, and M.J. Brodie Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005-2009 Epilepsia 51 2010 676 685
24. S. Auvin Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy Neuropsychiatr Dis Treat 3 2007 729 734
25. A. Biraben, H. Allain, and J.M. Scarabin Exacerbation of juvenile myoclonic epilepsy with lamotrigine Neurology 55 2000 1758
26. E.J. Carrazana, and S.D. Wheeler Exacerbation of juvenile myoclonic epilepsy with lamotrigine Neurology 56 2001 1424 1425
27. P. Kwan, and M.J. Brodie Early identification of refractory epilepsy N Engl J Med 342 2000 314 319
28. M.S. Guaranha, G.M. Filho, and K. Lin Prognosis of juvenile myoclonic epilepsy is related to endophenotypes Seizure 20 2011 42 48
29. B. Zifkin, E. Andermann, and F. Andermann Mechanisms, genetics, and pathogenesis of juvenile myoclonic epilepsy Curr Opin Neurol 18 2005 147 153
30. A.G. Marson, A.M. Al-Kharusi, and M. Alwaidh The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial Lancet 369 2007 1000 1015
31. M.T. Medina, I.E. Martinez-Juarez, and R.M. Duron Treatment of myoclonic epilepsies of childhood, adolescence, and adulthood Adv Neurol 95 2005 307 323